We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
NGLFINE.NSE

Price
1058.40
Stock movement down
-9.60 (-0.90%)
Company name
NGL Fine-Chem Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - General
Market cap
6.54B
Ent value
7.63B
Price/Sales
1.76
Price/Book
2.33
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
15.81
Forward P/E
-
PEG
-
EPS growth
15.47%
1 year return
-54.26%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-04-15

DIVIDENDS

NGLFINE.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E15.81
Price to OCF111.09
Price to FCF111.09
Price to EBITDA47.15
EV to EBITDA55.05

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales1.76
Price to Book2.33
EV to Sales2.05

FINANCIALS

Per share

Per share data
Current share count6.18M
EPS (TTM)66.94
FCF per share (TTM)9.53

Income statement

Income statement data
Revenue (TTM)3.72B
Gross profit (TTM)1.48B
Operating income (TTM)554.90M
Net income (TTM)413.64M
EPS (TTM)66.94
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)39.70%
Operating margin (TTM)14.92%
Profit margin (TTM)11.12%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash59.96M
Net receivables0.00
Total current assets2.35B
Goodwill1.53M
Intangible assets3.48M
Property, plant and equipment0.00
Total assets3.96B
Accounts payable530.08M
Short/Current long term debt492.03M
Total current liabilities884.50M
Total liabilities1.16B
Shareholder's equity2.80B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)58.86M
Capital expenditures (TTM)0.00
Free cash flow (TTM)58.86M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity14.76%
Return on Assets10.45%
Return on Invested Capital13.35%
Cash Return on Invested Capital1.90%

STOCK INFORMATION

Stock chart

Stock price data
Open1046.65
Daily high1060.00
Daily low1046.65
Daily Volume1K
All-time high2714.45
1y analyst estimate-
Beta1.08
EPS (TTM)66.94
Dividend per share-
Ex-div date14 Aug 2024
Next earnings date19 May 2025

Downside potential

Downside potential data
NGLFINE.NSES&P500
Current price drop from All-time high-61.01%-12.89%
Highest price drop-63.78%-56.47%
Date of highest drop18 Feb 20259 Mar 2009
Avg drop from high-20.32%-11.07%
Avg time to new high69 days12 days
Max time to new high246 days1805 days
COMPANY DETAILS
NGLFINE.NSE (NGL Fine-Chem Limited) company logo
Marketcap
6.54B
Marketcap category
Mid-cap
Description
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. The company offers animal health pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine hcl, s-methoprene, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, carprofen, fenbendazole, and xylazine hydrochloride. It also offers human health pharmaceutical ingredients comprising of nitazoxanide and atovaquone; and intermediates and specialty chemicals consisting of trimethyl, triazacylononane, and ethyl glucamine. In addition, the company provides finished dosage forms comprising of diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Employees
682
Website
https://www.nglfinechem.com
Investor relations
-
SEC filings
NGLFINE.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved